Phase II clinical trial with 5‐fluorouracil, recombinant interferon‐α‐2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.